Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06365788
Title Bicalutamide and Abemaciclib in Inoperable or Metastatic Androgen Receptor-positive Triple-negative Breast Cancer (ABBICAR)
Acronym ABBICAR
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Universitaire Ziekenhuizen KU Leuven
Indications
Therapies
Age Groups: adult | senior
Covered Countries BEL


No variant requirements are available.